nodes	percent_of_prediction	percent_of_DWPC	metapath
Griseofulvin—CYP3A4—Ifosfamide—testicular cancer	0.0849	0.308	CbGbCtD
Griseofulvin—CYP1A2—Etoposide—testicular cancer	0.0775	0.281	CbGbCtD
Griseofulvin—CYP3A4—Vinblastine—testicular cancer	0.0451	0.163	CbGbCtD
Griseofulvin—CYP3A4—Etoposide—testicular cancer	0.0406	0.147	CbGbCtD
Griseofulvin—Nephrotic syndrome—Chlorambucil—testicular cancer	0.0361	0.0498	CcSEcCtD
Griseofulvin—CYP3A4—Doxorubicin—testicular cancer	0.0277	0.1	CbGbCtD
Griseofulvin—Coagulopathy—Dactinomycin—testicular cancer	0.0162	0.0223	CcSEcCtD
Griseofulvin—Coagulopathy—Ifosfamide—testicular cancer	0.0148	0.0204	CcSEcCtD
Griseofulvin—Proteinuria—Ifosfamide—testicular cancer	0.0131	0.0181	CcSEcCtD
Griseofulvin—Protein urine present—Ifosfamide—testicular cancer	0.0129	0.0179	CcSEcCtD
Griseofulvin—Neuropathy peripheral—Chlorambucil—testicular cancer	0.00956	0.0132	CcSEcCtD
Griseofulvin—Neuropathy—Cisplatin—testicular cancer	0.00933	0.0129	CcSEcCtD
Griseofulvin—Neuropathy peripheral—Vinblastine—testicular cancer	0.00876	0.0121	CcSEcCtD
Griseofulvin—Candida infection—Etoposide—testicular cancer	0.00869	0.012	CcSEcCtD
Griseofulvin—Neuropathy—Etoposide—testicular cancer	0.00855	0.0118	CcSEcCtD
Griseofulvin—Gastrointestinal haemorrhage—Ifosfamide—testicular cancer	0.00837	0.0116	CcSEcCtD
Griseofulvin—Agranulocytosis—Vinblastine—testicular cancer	0.00834	0.0115	CcSEcCtD
Griseofulvin—Erythema multiforme—Chlorambucil—testicular cancer	0.00827	0.0114	CcSEcCtD
Griseofulvin—Oral candidiasis—Epirubicin—testicular cancer	0.00803	0.0111	CcSEcCtD
Griseofulvin—Oral candidiasis—Doxorubicin—testicular cancer	0.00743	0.0103	CcSEcCtD
Griseofulvin—Gastrointestinal haemorrhage—Cisplatin—testicular cancer	0.00721	0.00996	CcSEcCtD
Griseofulvin—Angioedema—Chlorambucil—testicular cancer	0.00696	0.00961	CcSEcCtD
Griseofulvin—Leukopenia—Chlorambucil—testicular cancer	0.00682	0.00941	CcSEcCtD
Griseofulvin—Agranulocytosis—Dactinomycin—testicular cancer	0.00657	0.00907	CcSEcCtD
Griseofulvin—Neuropathy peripheral—Ifosfamide—testicular cancer	0.00632	0.00873	CcSEcCtD
Griseofulvin—Hepatitis—Dactinomycin—testicular cancer	0.00632	0.00872	CcSEcCtD
Griseofulvin—Confusional state—Chlorambucil—testicular cancer	0.00627	0.00866	CcSEcCtD
Griseofulvin—Leukopenia—Vinblastine—testicular cancer	0.00625	0.00863	CcSEcCtD
Griseofulvin—Proteinuria—Methotrexate—testicular cancer	0.00621	0.00857	CcSEcCtD
Griseofulvin—Protein urine present—Methotrexate—testicular cancer	0.00612	0.00845	CcSEcCtD
Griseofulvin—Agranulocytosis—Ifosfamide—testicular cancer	0.00602	0.00831	CcSEcCtD
Griseofulvin—Hyperbilirubinaemia—Methotrexate—testicular cancer	0.006	0.00828	CcSEcCtD
Griseofulvin—Erythema multiforme—Dactinomycin—testicular cancer	0.00597	0.00825	CcSEcCtD
Griseofulvin—Erythema—Bleomycin—testicular cancer	0.0059	0.00814	CcSEcCtD
Griseofulvin—Hepatitis—Ifosfamide—testicular cancer	0.00579	0.00799	CcSEcCtD
Griseofulvin—Hepatic enzyme increased—Methotrexate—testicular cancer	0.00577	0.00796	CcSEcCtD
Griseofulvin—Hyperbilirubinaemia—Epirubicin—testicular cancer	0.00561	0.00775	CcSEcCtD
Griseofulvin—Erythema—Dactinomycin—testicular cancer	0.0055	0.00759	CcSEcCtD
Griseofulvin—Erythema multiforme—Ifosfamide—testicular cancer	0.00547	0.00756	CcSEcCtD
Griseofulvin—Dyspepsia—Chlorambucil—testicular cancer	0.00547	0.00756	CcSEcCtD
Griseofulvin—Neuropathy peripheral—Cisplatin—testicular cancer	0.00545	0.00752	CcSEcCtD
Griseofulvin—Fatigue—Chlorambucil—testicular cancer	0.00536	0.0074	CcSEcCtD
Griseofulvin—Leukopenia—Bleomycin—testicular cancer	0.00528	0.00729	CcSEcCtD
Griseofulvin—Hyperbilirubinaemia—Doxorubicin—testicular cancer	0.00519	0.00717	CcSEcCtD
Griseofulvin—Feeling abnormal—Chlorambucil—testicular cancer	0.00512	0.00707	CcSEcCtD
Griseofulvin—Paraesthesia—Vinblastine—testicular cancer	0.00512	0.00706	CcSEcCtD
Griseofulvin—Erythema—Ifosfamide—testicular cancer	0.00504	0.00696	CcSEcCtD
Griseofulvin—Neuropathy peripheral—Etoposide—testicular cancer	0.00499	0.00689	CcSEcCtD
Griseofulvin—Urticaria—Chlorambucil—testicular cancer	0.00494	0.00682	CcSEcCtD
Griseofulvin—Leukopenia—Dactinomycin—testicular cancer	0.00492	0.0068	CcSEcCtD
Griseofulvin—Candida infection—Epirubicin—testicular cancer	0.00487	0.00673	CcSEcCtD
Griseofulvin—Confusional state—Bleomycin—testicular cancer	0.00485	0.0067	CcSEcCtD
Griseofulvin—Neuropathy—Epirubicin—testicular cancer	0.00479	0.00662	CcSEcCtD
Griseofulvin—Agranulocytosis—Etoposide—testicular cancer	0.00475	0.00656	CcSEcCtD
Griseofulvin—Feeling abnormal—Vinblastine—testicular cancer	0.00469	0.00648	CcSEcCtD
Griseofulvin—Angioedema—Ifosfamide—testicular cancer	0.0046	0.00636	CcSEcCtD
Griseofulvin—Hypersensitivity—Chlorambucil—testicular cancer	0.00458	0.00632	CcSEcCtD
Griseofulvin—Leukopenia—Ifosfamide—testicular cancer	0.00451	0.00623	CcSEcCtD
Griseofulvin—Candida infection—Doxorubicin—testicular cancer	0.00451	0.00622	CcSEcCtD
Griseofulvin—Asthenia—Chlorambucil—testicular cancer	0.00446	0.00616	CcSEcCtD
Griseofulvin—Neuropathy—Doxorubicin—testicular cancer	0.00443	0.00612	CcSEcCtD
Griseofulvin—Erythema—Cisplatin—testicular cancer	0.00434	0.006	CcSEcCtD
Griseofulvin—Erythema multiforme—Etoposide—testicular cancer	0.00432	0.00597	CcSEcCtD
Griseofulvin—Paraesthesia—Bleomycin—testicular cancer	0.00432	0.00597	CcSEcCtD
Griseofulvin—Diarrhoea—Chlorambucil—testicular cancer	0.00425	0.00587	CcSEcCtD
Griseofulvin—Hypersensitivity—Vinblastine—testicular cancer	0.0042	0.0058	CcSEcCtD
Griseofulvin—Confusional state—Ifosfamide—testicular cancer	0.00415	0.00573	CcSEcCtD
Griseofulvin—Asthenia—Vinblastine—testicular cancer	0.00409	0.00564	CcSEcCtD
Griseofulvin—Feeling abnormal—Bleomycin—testicular cancer	0.00397	0.00547	CcSEcCtD
Griseofulvin—Vomiting—Chlorambucil—testicular cancer	0.00395	0.00546	CcSEcCtD
Griseofulvin—Diarrhoea—Vinblastine—testicular cancer	0.0039	0.00538	CcSEcCtD
Griseofulvin—Leukopenia—Cisplatin—testicular cancer	0.00389	0.00537	CcSEcCtD
Griseofulvin—Fatigue—Dactinomycin—testicular cancer	0.00387	0.00534	CcSEcCtD
Griseofulvin—Urticaria—Bleomycin—testicular cancer	0.00382	0.00528	CcSEcCtD
Griseofulvin—Dizziness—Vinblastine—testicular cancer	0.00377	0.0052	CcSEcCtD
Griseofulvin—Gastrointestinal haemorrhage—Epirubicin—testicular cancer	0.0037	0.00511	CcSEcCtD
Griseofulvin—Feeling abnormal—Dactinomycin—testicular cancer	0.0037	0.00511	CcSEcCtD
Griseofulvin—Nausea—Chlorambucil—testicular cancer	0.00369	0.0051	CcSEcCtD
Griseofulvin—Paraesthesia—Ifosfamide—testicular cancer	0.00369	0.0051	CcSEcCtD
Griseofulvin—Vomiting—Vinblastine—testicular cancer	0.00362	0.005	CcSEcCtD
Griseofulvin—Headache—Vinblastine—testicular cancer	0.00357	0.00493	CcSEcCtD
Griseofulvin—Leukopenia—Etoposide—testicular cancer	0.00356	0.00492	CcSEcCtD
Griseofulvin—Fatigue—Ifosfamide—testicular cancer	0.00355	0.0049	CcSEcCtD
Griseofulvin—Hypersensitivity—Bleomycin—testicular cancer	0.00355	0.00489	CcSEcCtD
Griseofulvin—Asthenia—Bleomycin—testicular cancer	0.00345	0.00477	CcSEcCtD
Griseofulvin—Gastrointestinal haemorrhage—Doxorubicin—testicular cancer	0.00343	0.00473	CcSEcCtD
Griseofulvin—Feeling abnormal—Ifosfamide—testicular cancer	0.00339	0.00468	CcSEcCtD
Griseofulvin—Nausea—Vinblastine—testicular cancer	0.00338	0.00467	CcSEcCtD
Griseofulvin—Hypersensitivity—Dactinomycin—testicular cancer	0.00331	0.00457	CcSEcCtD
Griseofulvin—Confusional state—Etoposide—testicular cancer	0.00327	0.00452	CcSEcCtD
Griseofulvin—Urticaria—Ifosfamide—testicular cancer	0.00327	0.00451	CcSEcCtD
Griseofulvin—Asthenia—Dactinomycin—testicular cancer	0.00322	0.00445	CcSEcCtD
Griseofulvin—Paraesthesia—Cisplatin—testicular cancer	0.00318	0.0044	CcSEcCtD
Griseofulvin—Diarrhoea—Dactinomycin—testicular cancer	0.00307	0.00424	CcSEcCtD
Griseofulvin—Vomiting—Bleomycin—testicular cancer	0.00306	0.00422	CcSEcCtD
Griseofulvin—Rash—Bleomycin—testicular cancer	0.00303	0.00419	CcSEcCtD
Griseofulvin—Dermatitis—Bleomycin—testicular cancer	0.00303	0.00419	CcSEcCtD
Griseofulvin—Hypersensitivity—Ifosfamide—testicular cancer	0.00303	0.00418	CcSEcCtD
Griseofulvin—Asthenia—Ifosfamide—testicular cancer	0.00295	0.00407	CcSEcCtD
Griseofulvin—Feeling abnormal—Cisplatin—testicular cancer	0.00292	0.00403	CcSEcCtD
Griseofulvin—Paraesthesia—Etoposide—testicular cancer	0.00292	0.00403	CcSEcCtD
Griseofulvin—Nausea—Bleomycin—testicular cancer	0.00286	0.00395	CcSEcCtD
Griseofulvin—Vomiting—Dactinomycin—testicular cancer	0.00285	0.00394	CcSEcCtD
Griseofulvin—Agranulocytosis—Methotrexate—testicular cancer	0.00285	0.00393	CcSEcCtD
Griseofulvin—Rash—Dactinomycin—testicular cancer	0.00283	0.00391	CcSEcCtD
Griseofulvin—Diarrhoea—Ifosfamide—testicular cancer	0.00281	0.00388	CcSEcCtD
Griseofulvin—Fatigue—Etoposide—testicular cancer	0.0028	0.00387	CcSEcCtD
Griseofulvin—Neuropathy peripheral—Epirubicin—testicular cancer	0.0028	0.00386	CcSEcCtD
Griseofulvin—Hepatitis—Methotrexate—testicular cancer	0.00274	0.00378	CcSEcCtD
Griseofulvin—Dizziness—Ifosfamide—testicular cancer	0.00272	0.00375	CcSEcCtD
Griseofulvin—Feeling abnormal—Etoposide—testicular cancer	0.00268	0.0037	CcSEcCtD
Griseofulvin—Nausea—Dactinomycin—testicular cancer	0.00267	0.00368	CcSEcCtD
Griseofulvin—Agranulocytosis—Epirubicin—testicular cancer	0.00266	0.00368	CcSEcCtD
Griseofulvin—Vomiting—Ifosfamide—testicular cancer	0.00261	0.00361	CcSEcCtD
Griseofulvin—Hypersensitivity—Cisplatin—testicular cancer	0.00261	0.00361	CcSEcCtD
Griseofulvin—Rash—Ifosfamide—testicular cancer	0.00259	0.00358	CcSEcCtD
Griseofulvin—Dermatitis—Ifosfamide—testicular cancer	0.00259	0.00358	CcSEcCtD
Griseofulvin—Erythema multiforme—Methotrexate—testicular cancer	0.00259	0.00357	CcSEcCtD
Griseofulvin—Neuropathy peripheral—Doxorubicin—testicular cancer	0.00259	0.00357	CcSEcCtD
Griseofulvin—Urticaria—Etoposide—testicular cancer	0.00258	0.00356	CcSEcCtD
Griseofulvin—Hepatitis—Epirubicin—testicular cancer	0.00256	0.00354	CcSEcCtD
Griseofulvin—Asthenia—Cisplatin—testicular cancer	0.00254	0.00351	CcSEcCtD
Griseofulvin—Agranulocytosis—Doxorubicin—testicular cancer	0.00246	0.0034	CcSEcCtD
Griseofulvin—Nausea—Ifosfamide—testicular cancer	0.00244	0.00337	CcSEcCtD
Griseofulvin—Diarrhoea—Cisplatin—testicular cancer	0.00243	0.00335	CcSEcCtD
Griseofulvin—Erythema multiforme—Epirubicin—testicular cancer	0.00242	0.00335	CcSEcCtD
Griseofulvin—Hypersensitivity—Etoposide—testicular cancer	0.00239	0.0033	CcSEcCtD
Griseofulvin—Erythema—Methotrexate—testicular cancer	0.00238	0.00329	CcSEcCtD
Griseofulvin—Hepatitis—Doxorubicin—testicular cancer	0.00237	0.00327	CcSEcCtD
Griseofulvin—Asthenia—Etoposide—testicular cancer	0.00233	0.00322	CcSEcCtD
Griseofulvin—Vomiting—Cisplatin—testicular cancer	0.00225	0.00311	CcSEcCtD
Griseofulvin—Erythema multiforme—Doxorubicin—testicular cancer	0.00224	0.0031	CcSEcCtD
Griseofulvin—Rash—Cisplatin—testicular cancer	0.00224	0.00309	CcSEcCtD
Griseofulvin—Dermatitis—Cisplatin—testicular cancer	0.00223	0.00308	CcSEcCtD
Griseofulvin—Erythema—Epirubicin—testicular cancer	0.00223	0.00308	CcSEcCtD
Griseofulvin—Diarrhoea—Etoposide—testicular cancer	0.00222	0.00307	CcSEcCtD
Griseofulvin—Dizziness—Etoposide—testicular cancer	0.00215	0.00297	CcSEcCtD
Griseofulvin—Leukopenia—Methotrexate—testicular cancer	0.00213	0.00295	CcSEcCtD
Griseofulvin—Nausea—Cisplatin—testicular cancer	0.00211	0.00291	CcSEcCtD
Griseofulvin—Vomiting—Etoposide—testicular cancer	0.00207	0.00285	CcSEcCtD
Griseofulvin—Erythema—Doxorubicin—testicular cancer	0.00206	0.00285	CcSEcCtD
Griseofulvin—Rash—Etoposide—testicular cancer	0.00205	0.00283	CcSEcCtD
Griseofulvin—Dermatitis—Etoposide—testicular cancer	0.00205	0.00282	CcSEcCtD
Griseofulvin—Headache—Etoposide—testicular cancer	0.00203	0.00281	CcSEcCtD
Griseofulvin—Leukopenia—Epirubicin—testicular cancer	0.002	0.00276	CcSEcCtD
Griseofulvin—Confusional state—Methotrexate—testicular cancer	0.00196	0.00271	CcSEcCtD
Griseofulvin—Nausea—Etoposide—testicular cancer	0.00193	0.00266	CcSEcCtD
Griseofulvin—Leukopenia—Doxorubicin—testicular cancer	0.00185	0.00255	CcSEcCtD
Griseofulvin—Confusional state—Epirubicin—testicular cancer	0.00184	0.00253	CcSEcCtD
Griseofulvin—Insomnia—Methotrexate—testicular cancer	0.00176	0.00243	CcSEcCtD
Griseofulvin—Paraesthesia—Methotrexate—testicular cancer	0.00175	0.00241	CcSEcCtD
Griseofulvin—Dyspepsia—Methotrexate—testicular cancer	0.00171	0.00236	CcSEcCtD
Griseofulvin—Confusional state—Doxorubicin—testicular cancer	0.0017	0.00235	CcSEcCtD
Griseofulvin—Fatigue—Methotrexate—testicular cancer	0.00168	0.00232	CcSEcCtD
Griseofulvin—Insomnia—Epirubicin—testicular cancer	0.00165	0.00227	CcSEcCtD
Griseofulvin—Paraesthesia—Epirubicin—testicular cancer	0.00163	0.00226	CcSEcCtD
Griseofulvin—Feeling abnormal—Methotrexate—testicular cancer	0.0016	0.00221	CcSEcCtD
Griseofulvin—Dyspepsia—Epirubicin—testicular cancer	0.0016	0.00221	CcSEcCtD
Griseofulvin—Fatigue—Epirubicin—testicular cancer	0.00157	0.00217	CcSEcCtD
Griseofulvin—Urticaria—Methotrexate—testicular cancer	0.00155	0.00213	CcSEcCtD
Griseofulvin—Insomnia—Doxorubicin—testicular cancer	0.00152	0.0021	CcSEcCtD
Griseofulvin—Paraesthesia—Doxorubicin—testicular cancer	0.00151	0.00209	CcSEcCtD
Griseofulvin—Feeling abnormal—Epirubicin—testicular cancer	0.0015	0.00207	CcSEcCtD
Griseofulvin—Dyspepsia—Doxorubicin—testicular cancer	0.00148	0.00205	CcSEcCtD
Griseofulvin—Fatigue—Doxorubicin—testicular cancer	0.00145	0.00201	CcSEcCtD
Griseofulvin—Urticaria—Epirubicin—testicular cancer	0.00145	0.002	CcSEcCtD
Griseofulvin—Hypersensitivity—Methotrexate—testicular cancer	0.00143	0.00198	CcSEcCtD
Griseofulvin—Asthenia—Methotrexate—testicular cancer	0.0014	0.00193	CcSEcCtD
Griseofulvin—Feeling abnormal—Doxorubicin—testicular cancer	0.00139	0.00192	CcSEcCtD
Griseofulvin—Hypersensitivity—Epirubicin—testicular cancer	0.00134	0.00185	CcSEcCtD
Griseofulvin—Urticaria—Doxorubicin—testicular cancer	0.00134	0.00185	CcSEcCtD
Griseofulvin—Diarrhoea—Methotrexate—testicular cancer	0.00133	0.00184	CcSEcCtD
Griseofulvin—Asthenia—Epirubicin—testicular cancer	0.00131	0.0018	CcSEcCtD
Griseofulvin—Dizziness—Methotrexate—testicular cancer	0.00129	0.00178	CcSEcCtD
Griseofulvin—Diarrhoea—Epirubicin—testicular cancer	0.00125	0.00172	CcSEcCtD
Griseofulvin—Hypersensitivity—Doxorubicin—testicular cancer	0.00124	0.00171	CcSEcCtD
Griseofulvin—Vomiting—Methotrexate—testicular cancer	0.00124	0.00171	CcSEcCtD
Griseofulvin—Rash—Methotrexate—testicular cancer	0.00123	0.00169	CcSEcCtD
Griseofulvin—Dermatitis—Methotrexate—testicular cancer	0.00123	0.00169	CcSEcCtD
Griseofulvin—Headache—Methotrexate—testicular cancer	0.00122	0.00168	CcSEcCtD
Griseofulvin—Asthenia—Doxorubicin—testicular cancer	0.00121	0.00167	CcSEcCtD
Griseofulvin—Dizziness—Epirubicin—testicular cancer	0.0012	0.00166	CcSEcCtD
Griseofulvin—Vomiting—Epirubicin—testicular cancer	0.00116	0.0016	CcSEcCtD
Griseofulvin—Nausea—Methotrexate—testicular cancer	0.00116	0.0016	CcSEcCtD
Griseofulvin—Diarrhoea—Doxorubicin—testicular cancer	0.00115	0.00159	CcSEcCtD
Griseofulvin—Rash—Epirubicin—testicular cancer	0.00115	0.00158	CcSEcCtD
Griseofulvin—Dermatitis—Epirubicin—testicular cancer	0.00115	0.00158	CcSEcCtD
Griseofulvin—Headache—Epirubicin—testicular cancer	0.00114	0.00157	CcSEcCtD
Griseofulvin—Dizziness—Doxorubicin—testicular cancer	0.00111	0.00154	CcSEcCtD
Griseofulvin—Nausea—Epirubicin—testicular cancer	0.00108	0.00149	CcSEcCtD
Griseofulvin—Vomiting—Doxorubicin—testicular cancer	0.00107	0.00148	CcSEcCtD
Griseofulvin—Rash—Doxorubicin—testicular cancer	0.00106	0.00147	CcSEcCtD
Griseofulvin—Dermatitis—Doxorubicin—testicular cancer	0.00106	0.00147	CcSEcCtD
Griseofulvin—Headache—Doxorubicin—testicular cancer	0.00106	0.00146	CcSEcCtD
Griseofulvin—Nausea—Doxorubicin—testicular cancer	0.001	0.00138	CcSEcCtD
